The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more convenient fashion for those taking the drug over the long run.
University of Oxford research revealed groundbreaking findings that could reshape dementia prevention. Ozempic (AKA Semaglutide/Wegovy), a type-2 diabetes and weight-loss drug, seems to significantly reduce the risk of dementia.
A drug for Alzheimer’s, called Leqembi, might soon be given less often. Right now, patients get it through a drip every two weeks. The idea is to change this to once a month.
While Resveratrol supplements decrease brain swelling, they increase brain shrinkage. Is the trade-off worthwhile?
Bezisterim can manage inflammation and enhance energy transfer (insulin sensitivity) in the brain. Learn how it is in trials to improve memory and thinking in Alzheimer’s.
The newest and most promising drug to fight Alzheimer’s is Leqembi. Carolyn Davis is giving it a try. Learn about the promise, the risks and how it has restored her hope,
Scheduled to begin on May 9, 2024, six new monthly sessions are now available in this free Continuing Education Program.
Removing ovaries with a hysterectomy might increase risk of heart disease, stroke and dementia.
The Therapeutic Gardens project in Italy has been studied, certified and recognized for excellence. Dementia patients improve memory, cognitive functions, language, mood and above all, they need less medication.
Fiber improved performance in memory tests associated with early Alzheimer’s in just 12 weeks.
Fiber is cheap, available as over-the counter supplements, safe and just right for these cash-strapped times.
MOTHER’S DAY USA, MAY 11, can remain a meaningful and enjoyable occasion for families impacted by Alzheimer’s. Planning takes more thought and each family’s unique circumstances need to be considered. These tips can help:
TEEPA SNOW explains how to handle caregiver stress that is brought on by challenging behaviors in dementias such as Alzheimer’s.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
